Institutional Ownership Acrivon Therapeutics, Inc. (ACRV)
This table provides information about the institutional ownership of Acrivon Therapeutics, Inc. (ACRV). We have compiled data on the 59 institutions that hold shares in the stock, with a total of 22.6 Million shares, which have been reported (via 13F filing form) to have a value of $0.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Redwood Park Advisors LLC
Redwood City, CA |
May 06, 2025 Q1 2025 |
500
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
May 15, 2025 Q1 2025 |
400
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
Amalgamated Bank
New York, NY |
Apr 25, 2025 Q1 2025 |
378
shares
|
$0
0.0% of portfolio
|
Q1 2024
Reduced 69.29%
|
|
Sterling Capital Management LLC
Charlotte, NC |
May 13, 2025 Q1 2025 |
198
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 50.62%
|
|
Avion Wealth
The Woodlands, TX |
May 09, 2025 Q1 2025 |
88
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
74
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|
|
Cwm, LLC
|
May 01, 2025 Q1 2025 |
49
shares
|
$0
0.0% of portfolio
|
Q1 2025
Added 19.51%
|
|
True Wealth Design, LLC
Akron, OH |
May 13, 2025 Q1 2025 |
3
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|